Assertio holdings, inc. reports inducement grants under nasdaq listing rule 5635(c)(4)

Lake forest, ill., jan. 05, 2024 (globe newswire) -- assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of patients, announced that effective january 2, 2024, the compensation committee of the company's board of directors granted two newly-hired employee a total of 16,498 restricted stock units (“rsus”) and 18,654 stock options (“options”).
ASRT Ratings Summary
ASRT Quant Ranking